Cudraxanthone D (CD), derived from the root bark of Cudrania tricuspidata, is a natural xanthone compound. However, the biological activity of CD in terms of human metabolism has been barely reported to date. Autophagy is known as a selfdegradation process related to cancer cell viability and metastasis. Herein, we investigated the effects of CD on human oral squamous cell carcinoma (OSCC) metastatic related cell phenotype. We confirmed that CD effectively decreased proliferation and viability in a time-and dose-dependent manner in human OSCC cells. In addition, OSCC cell migration, invasion, and EMT were inhibited by CD. To further determine the underlying mechanism of CD's inhibition of cell metastatic potential, we established the relationship between EMT and autophagy in OSCC cells. us, our findings indicated that CD inhibited the potential metastatic abilities of OSCC cells by attenuating autophagy.
Introduction
Autophagy is a biological process that protects against cellular homeostasis disruption from intracellular or environmental stresses, such as hypoxia, starvation, and cytochemism [1] . During autophagic processes, doublemembrane vesicles, called autophagosomes, sequester cytoplasmic organelles and carry them to lysosomes. Lastly, autophagosome-fused lysosomes are degraded [2] . Autophagy is related to many pathological and physiological processes, such as apoptosis and cancer metastasis. e role of autophagy in tumor cells is known as a "dual-edged sword"-it may function as a tumor suppressor by protecting proteins from damage during the tumor formation stage, while in terms of tumor growth, autophagy might be a tumor promoter by distributing substrates for metabolic balance. Recently, much evidence of autophagy function in cancer has been reported such that it is key in the development of chemotherapeutic agents [3] [4] [5] [6] .
Tumor metastasis is divided into sequences of stages. Of the multistep processes, epithelial-mesenchymal transition (EMT) is concerned with local invasion [7] , by which, when it is initiated, epithelial cells lose their properties and are transformed into different types of cells with mesenchymal properties, thereby increasing cell mobility and migration [8] . e interplay between autophagy and EMT has been thought for a long time to be connected. One study reported that increasing autophagy supports various cancer cells' EMT during spreading by upregulating cell motility [9] [10] [11] . On the other hand, there are data that indicate that autophagy prevents tumor cells from engaging in EMT by activating autophagic process and returning to the EMT phenotype. Synthetically, it is important to control autophagy and EMT interactions for regulation of tumor metastasis [12] [13] [14] .
Cudraxanthone D (CD), a natural xanthone compound, is derived from the root bark of Cudrania tricuspidata distributed widely in Korea, Japan, and China [15] . Its compounds are used as traditional drugs for many diseases [16] [17] [18] [19] . However, the relationship among oral squamous cell carcinoma (OSCC), autophagy, and EMT is unknown. So, in this study, we investigate what the role of autophagy is in OSCC cell metastatic cell phenotype and elucidate whether CD might be a strategically novel agent in oral cancer cell migration and invasion.
As is well known, autophagy and EMT are major biological processes in the occurrence and development of cancer, and there is a complex relationship between autophagy and EMT signaling pathways.
Materials and Methods

Reagents. Fetal bovine serum (FBS), Dulbecco's mod-
ified Eagle medium (DMEM), and DMEM : nutrient mixture F-12 (DMEM/F-12) were obtained from ermo Fisher Scientific (Pittsburgh, USA). CD was purchased from ChemFace (Wuhan, China). 3-[4,5-Dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide (MTT) and dimethyl sulfoxide (DMSO) were procured from Duchefa Biochemie (Haarlem, the Netherlands). Rabbit antibodies, E-cadherin, slug, snail, ATG5, beclin-1, and LC3B were purchased from Cell Signaling Technology (Beverly, USA). e anti-mouse HRP-conjugated secondary antibody and anti-rabbit HRPconjugated secondary antibody were obtained from Enzo Biochem (Farmingdale, USA). Acridine orange and 3MA (3methyladenine) were obtained from Sigma-Aldrich (St. Louis, USA).
Cell Culture.
e Ca9-22, SCC25, and CAL27 cells were procured from America Type Culture Collection (Manassas, USA). HSC4 cells were provided by Professor Sung-Dae Cho of the Department of Oral Pathology, School of Dentistry, Chonbuk National University (Jeonju, Korea). Ca9-22 and CAL27 cells were cultured in DDMEM, ermo Fisher Scientific (Pittsburgh, USA), while the SCC25 cells were cultured in DMEM/F-12. HSC4 cells were cultured in MEM with 10% FBS and 1% penicillin-streptomycin at 37°C in a humidified 5% carbon dioxide (CO 2 ) atmosphere. CD was dissolved in DMSO at a stock solution of 10 mM and was kept at 4°C. e CD stock solution was diluted to marked concentrations with medium when we required.
Cell Viability Measurement.
e cell viability of OSCC cells was determined using an MTT assay. Cells were cultured in 96-well plates and then incubated for different time periods in the presence of various concentrations of CD (0-100 μM). After terminating the treatment, the medium was removed and 100 μl of MTT (500 mg/mL) was added to each well. e cells were incubated for 3 h at 37°C to form formazan crystals. e formazan crystals were measured as described in the previous study [20] .
Wound Healing Assay.
A wound healing assay was performed to investigate the cell proliferation and migration ability of OSCC cells. Cells were seeded to roughly 80-90% confluence into six-well plates. A 1 mm pipette tip was used to formulate wounds, and debris was washed with PBS twice. Migrated cells into the wound area were visualized under an inverted microscope at 200x magnification (Olympus, Tokyo, Japan).
Migration and Invasion
Assay. Cell invasion assay (transwell assay) and migration assay were conducted to examine the capacity of cell invasion and migration, as described previously. A transwell with an 8 μm pore polycarbonate membrane (Corning Costar, Cambridge, USA) was coated with 40 μl Matrigel at 200 μg/ml and incubated for 2 h. Next, OSCC cells were seeded and treated with 3MA, resveratrol, and CD. e upper chamber of the transwell was filled with serum-free medium and the lower chamber with 800 μl medium containing 10% FBS for 72 h of incubation at 37°C in a humidified 5% CO 2 atmosphere. e cells were fixed in methanol and stained with hematoxylin for 30 min and were then counted under an inverted microscope (Olympus, Tokyo, Japan).
Immunofluorescent Staining. OSCC cells were cultured
in DMEM with 3MA, resveratrol, and CD on a Lab-Tek ™ II Chamber Slide (Nunc; ermo Fisher Scientific, Rochester, USA). After 24 h, cells were stained with acridine orange (Sigma-Aldrich, St. Louis, USA). Fluorescent images were observed and analyzed as described in the previous study [20] .
Western Blot
Assay. Cells were harvested in the form of pellets, and then it was lysed in 150 μl RIPA buffer (300 mM NaCl, 50 mM Tris-Cl (pH 7.6), 0.5% Triton X-100, 2 mM PMSF, 2 μl/ml aprotinin, and 2 μl/ml leupeptin/protease inhibitor cocktail) and incubated at 4°C for 1 h. e lysate was centrifuged at 13,200 RPM for 30 minutes at 4°C. Protein quantification, electrophoresis, and detection of protein expression were performed in the same manner as described in the previous study [20] .
Statistical Analysis.
All data represent mean ± SD (standard deviation). Statistical analyses were conducted using one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison test. A difference of p value less than 0.05 was considered significant.
Results
Cudraxanthone D Affects Cell Viability in Human OSCC
Cell Lines. To choose proper concentrations of CD, human OSCC cell lines, specifically Ca9-22, CAL27, SCC25, and HSC4 cells, were cultured with 0-100 μM CD for 24-72 h. After treatment, cell viability was determined using an MTT assay. As shown in Figure 1 , CD was cytotoxic to OSCC cells in a dose-and time-dependent manner. In particular, Ca9-22 and SCC25 cells were very sensitive to CD. So, these cells were selected and the subsequent experiments were carried out.
Cudraxanthone D Suppresses Epithelial-Mesenchymal
Transition in Ca9-22 and SCC25 Cells. To determine whether CD affected OSCC cell cancer metastatic phenotype, we conducted a wound healing assay, transwell assay, and western blotting. Cell migration capabilities were investigated by the wound healing assay and transwell assay without Matrigel. e results demonstrated that the scratch wound area of the nontreated group was covered with proliferating Ca9-22 and SCC25 cells by approximately 55% while in the CD-treated group, the wound area covered only approximately 10% and 11% compared to prescratching, respectively (Figures 2(a) and 2(b)). In addition, we performed the transwell assay to verify migration capability in the absence of Matrigel, also known as a migration assay. First, Ca9-22 and SCC25 cell suspensions were located in the upper chamber with serum-starved media, while the lower chamber was filled with normal media. After 24 h, the nontreated group of Ca9-22 and SCC25 cells was found on the underside of the transwell filter. However, with the CDtreated group, there was a dramatic reduction in the migration capability of both cells by approximately 10% and 2%, respectively (Figure 3(a) ). Similar results were found with the invasion assay, with applied Matrigel in the upper chamber. e CD-treated group exhibited inhibited invasion capabilities for both cells compared to the control groups (Figure 3(b) ). Moreover, we confirmed the expression of EMT-associated proteins, such as E-cadherin, slug, and snail as shown in Figures 3(c) and 3(d) . CD significantly upregulated E-cadherin, while slug expression was scarcely changed in both cells. Variation in snail expression was observed quite pronouncedly in Ca9-22. Collectively, these results suggested that CD effectively suppressed the EMT of OSCC cell lines. . A variety of evidence indicated that autophagy induction is associated with tumor cell EMT in various cancers [5, 14] . Hence, in order to analyze the underlying mechanisms of CDinhibited EMT, among diverse autophagy inducers, resveratrol has attracted attention, recently [21] [22] [23] [24] . In our previous study, we confirmed that resveratrol induced autophagy in OSCC cell lines [25] . So, we employed resveratrol as an autophagy inducer and performed AO (acridine orange) staining and western blotting. Our findings demonstrated that resveratrol increased AO-positive autophagic vacuoles, and a typical autophagy inhibitor, 3MA, decreased the number of AO-positive cells. CD also remarkably diminished autophagic vacuoles compared to the resveratrol-treated group (Figure 4(a) ). As shown in Figures 4(b) and 4(c), resveratrol upregulated autophagyrelated proteins (ATG5, p62, and LC3B) inhibited by 3MA. CD also inhibited resveratrol-induced autophagy, with 3MA and CD cotreatment more effective against resveratrol-induced autophagy compared to single treatment. e aforementioned results suggested that CD acts as an autophagy inhibitor, while 3MA and CD dual treatment effectively suppressed resveratrol-induced autophagy.
Suppression of Resveratrol-Induced Autophagy by Cudraxanthone D Affected EMT in
We hypothesize that CD and 3MA inhibited autophagyaffected migration and EMT in Ca9-22 cells in accordance with previous studies. To validate the hypothesis, wound healing assay and transwell assay (migration assay) were performed. e results indicated that the wound area of the resveratrol-treated group was almost filled with migrated cells. However, the wound area of the 3MA-pretreated and CD-treated groups was not reduced compared to control and resveratrol-administered groups (Figures 5(a) and 5(b) ). Similarly, cell migration was induced by resveratrol treatment, and this induction was inhibited by 3MA and CD. Meanwhile, the expression levels of slug and snail, with mesenchymal properties, increased with resveratrol. Overexpression of slug and snail was inhibited by 3MA and CD. Additionally, dual treatment of 3MA and CD was more effective with respect to EMT protein expression inhibition than treatment alone. ese data suggest that the application of CD effectively suppressed resveratrol-induced OSCC EMT and CD could be a novel autophagy inhibitor.
Discussion
Over the past several decades, numerous dietary plantextracted medicines have been used for human cancer. Although various evidence has indicated the advantages of many natural compounds, the OSCC five-year survival rate has been lower (approximately less than 50%) owing to many other reasons [26] [27] [28] . Among natural compounds, the Cudrania tricuspidata root bark isolated components, having a xanthone skeleton, have exhibited various biological activities [19, 29, 30] . Cudraxanthone H, with a prenylated xanthone, impacts OSCC growth inhibition and apoptosis [16] . Also, gerontoxanthone A, cudraflavone B, and gericudranin E obtained from the root bark of Cudrania tricuspidata have hepatoprotective effects [31] . Otherwise, plenty of xanthone series compounds have been used for various studies [26, [32] [33] [34] [35] . Yet, there is no report on CD, which possesses a xanthone skeleton with a hydrogencombined hydroxyl group and mutually ortho-located hydroxyl groups, elements of root bark of Cudrania tricuspidata in human OSCC [15] . In this study, for the first time, we focused on antimetastatic effects and chemotherapeutic potential of CD against OSCC. First, we explored the cytotoxic effects of CD on four types of OSCC. Applications of 0 to 100 μM concentrations of CD inhibited cell growth in a dose-and time-dependent manner. Among them, Ca9-22 and SCC25 cells were more sensitive to CD than other cell lines. Recurrence and mortality rates of cancer mostly were regulated by metastasis and invasion of tumor cells, especially OSCC that chiefly metastasizes to the lymph nodes of cervical regions, fatal during prognosis [36] [37] [38] . Additional experiments such as wound healing assay, transwell assay, and western blot to detect expression levels of EMT-related protein indicated that CD remarkably suppressed cell migration, invasion, and EMT in Ca9-22 and SCC25 cells. To investigate the EMT inhibition mechanisms of CD, we concentrated on autophagy-regulated Ca9-22 cell EMT.
More research studies have reported that autophagy has a close correlation with cancer cell migration and invasion capability. A previous study suggested that compressive stress upregulates autophagy, and this status leads to enhanced migration of HeLa cells [39] . Further, Gao et al. reported that glycochenodeoxycholate supports HCC cell invasion and migration through autophagy activation [40] . Moreover, inhibition of autophagy with chloroquine attenuates metastatic ability in human non-small-cell lung adenocarcinoma A549 cells [5] . For these reasons, we formulated a hypothesis that CD-inhibited cell EMT ability is related to autophagy in OSCC cells. As an autophagy inducer, resveratrol is used on the basis of a number of earlier studies [21, 23, [41] [42] [43] . In our previous study, we evaluated the noncytotoxic concentration of resveratrol [25] , where we induced autophagy by 25 μM of resveratrol.
As expected, resveratrol induced AO-positive autophagic vesicles and expressions of autophagy markers (ATG5, p62, and LC3B). 3MA, known as a typical autophagy inhibitor, suppressed resveratrol-induced autophagic activity. CD also inhibited resveratrol-induced autophagic actions. In order to elucidate the mechanism between resveratrol-induced autophagy and OSCC migration as well as invasion capability, we performed wound healing assay, transwell assay without Matrigel, and a western blot assay (EMTrelated factors) under the same conditions as in Figure 4 . e results demonstrated that autophagy induction enhanced cell migration ability and EMT factor expressions in Ca9-22 cells. Inhibition of autophagy by 3MA decreased Ca9-22 cell motility and EMT-related protein expression compared to the resveratrol-treated group. Suppression of EMT by CD was more effective than that by 3MA. Additionally, 3MA and CD cotreatment dramatically inhibited EMT compared with a single treatment. ese results suggested that CD could be an EMT suppressor through autophagy inhibition.
Conclusion
e present study demonstrated that the molecular mechanism underlying the chemotherapeutic properties is that CD could inhibit metastatic related phenotype in human OSCC cells by inhibiting autophagy. We are suggesting that CD has sufficient potential for development as a new anticancer drug.
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